Monitoring of angiogenesis and PD-L1 expression by immunofluorescence staining also showed that the number of angiogenesis and the expression level of PD-L1 in the tumor microenvironment were also significantly reduced after combined treatment, which positively correlated with therapeutic efficacy in orthotopic lung cancer models (Fig. 4I, J). This evidence concerns the gene CD274 and neoplasm.